Clinical Trial Update: Cardiotoxicity in Breast Cancer Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to investigate cardiotoxicity in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Helwan University | Conditions: Breast Cancer | Phase 4 | Status: RECRUITING